Researchers at the Georgia Institute of Technology have developed a targeted therapy using nanohydrogels to stunt the growth of ovarian tumors in in vivo tests in mice, according to a new study.
The nanohydrogel is a gel pellet that researchers can load with RNA to carry into cancer cells and knock down a particular protein.
“The dramatic effect we see is the massive reduction or complete eradication of the tumor, when the ‘nanohydrogel’ treatment is given in combination with existing chemotherapy,” chief researcher John McDonald said in prepared remarks.
Get the full story at our sister site, Drug Delivery Business News.